← All drugs Report issue

1d09c3

mAbexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

HLA class II histocompatibility antigen, DR alpha chainINHIBITOR
HLA-DRA inhibitor
- HLA class II histocompatibility antigen, DR alpha chain (HLA-DRA) ↗

Chemistry & pharmacology

Chirality: Single Stereoisomer
Inorganic: No
Polymer: No
Multi-specific: No

Oral

No

Parenteral

No

Topical

No

Sources

ChEMBLCHEMBL2109518 ↗

Also known as

1d09c3
1d09c3